2025 Ninth District President
Dr. Renuka Bijoor
CE Registry is now CE Navigator
Navigate your continuing education journey with ease using the CE Navigator, your ultimate guide to professional development.
ADA Update: a new login experience
We’re updating how you log in to your NYSDA and ADA account.
RENEW YOUR MEMBERSHIP TODAY!
3 EASY WAYS TO PAY 1 ONLINE: nysdental.org/renew 2 MAIL: Return dues stub and payment 3 PHONE: 1-800-255-2100
New Exclusive NYSDA Member Benefit
Life comes with challenges, but your new Member Assistance Program (MAP) is here to help. This free, confidential benefit is available to you and your household, offering resources and services to support mental health, reduce stress, and make life easier.
The Ninth District Dental Society was formed in 1909 and renamed to the Ninth District Dental Association in 2002. We have a membership of over 1500 dentists in 5 counties: Westchester, Rockland, Dutchess, Orange and Putnam.
In its quest to serve both the public and the profession, the Ninth District embodies the highest ideals.
The mission of the 9th District Dental Association is to serve and support its members and the public by improving the oral health of our community through Advocacy, Continuing Education and Camaraderie.
Per the notice below, the United States Food and Drug Administration (FDA) is holding a meeting of its Digital Health Advisory Committee that will be Webcast for free.
The Digital Health Advisory Committee Will Meet to Discuss Total Product Lifecycle Considerations for Generative AI-enabled Medical Devices
Important Deadlines
Questions?If you have questions about the Digital Health Advisory Committee, e-mail: james.swink@fda.hhs.gov. |
.png?sfvrsn=4447de7f_1)
The U.S. Food and Drug Administration (FDA) is announcing that the inaugural Digital Health Advisory Committee meeting will occur November 20-21, 2024. Registration is not required to attend. During this meeting, the advisory committee will discuss total product lifecycle considerations for generative AI-enabled medical devices. The committee will also discuss how the use of generative AI-may impact safety and effectiveness of medical devices enabled with this technology. The Committee will discuss premarket performance evaluation, risk management, and postmarket performance monitoring for generative AI-enabled devices.